1.Silencing GmWRKY33B genes leads to reduced disease resistance in soybean.
Chenli ZHONG ; Wenxu WANG ; Lina LIAO ; Jianzhong LIU
Chinese Journal of Biotechnology 2024;40(1):163-176
The WRKYs are a group of plant-specific transcription factors that play important roles in defense responses. In this study, we silenced 2 GmWRKY33B homologous genes using a bean pod mosaic virus (BPMV) vector carrying a single fragment from the conserved region of the GmWRKY33B genes. Silencing GmWRKY33B did not result in morphological changes. However, significantly reduced resistances to Pseudomonas syringae pv. glycinea (Psg) and soybean mosaic virus (SMV) were observed in the GmWRKY33B-silenced plants, indicating a positive role of the GmWRKY33B genes in disease resistance. Kinase assay showed that silencing the GmWRKY33B genes significantly reduced the activation of GmMPK6, but not GmMPK3, in response to flg22 treatment. Reverse transcriptase PCR (RT-PCR) analysis of the genes encoding prenyltransferases (PTs), which are the key enzymes in the biosynthesis of glyceollin, showed that the Psg-induced expression of these genes was significantly reduced in the GmWRKY33B-silenced plants compared with the BPMV-0 empty vector plants, which correlated with the presence of the W-boxes in the promoter regions of these genes. Taken together, our results suggest that GmWRKY33Bs are involved in soybean immunity through regulating the activation of the kinase activity of GmMPK6 as well as through regulating the expression of the key genes encoding the biosynthesis of glyceollins.
Glycine max/genetics*
;
Disease Resistance/genetics*
;
Biological Assay
;
Dimethylallyltranstransferase
;
Gene Silencing
2.Research Progress of Iron Metabolism in Disease Progression and Drug Resistance of Multiple Myeloma--Review.
Yan-Ying LI ; Liu-Yun ZHANG ; Yun-Hui XIANG ; Juan ZHANG
Journal of Experimental Hematology 2023;31(6):1916-1920
Iron metabolism is involved in the development and drug resistance of many malignancies, including multiple myeloma (MM). Based on recent studies on iron metabolism and MM, this paper reviews the relationship between iron metabolism and disease process of MM in terms of iron overload leading to ferroptosis in MM cells, the role of iron deficiency in oxidative respiration and proliferation of MM cells, and the interaction between ferroptosis and autophagy in the disease process. The mechanisms by which iron metabolism-related substances lead to MM cells' resistance to proteasome inhibitors (PI) through inducing redox imbalance and M2 macrophage polarization are also briefly described, aiming to provide a theoretical basis for the application of iron metabolism-related drugs to the clinical treatment of MM patients.
Humans
;
Autophagy
;
Disease Progression
;
Iron/metabolism*
;
Multiple Myeloma
;
Drug Resistance, Neoplasm
3.Clinical efficacy of Kuanxiong aerosol in the treatment of coronary microvascular disease assessed by coronary angiography-derived index of microcirculatory resistance: three cases report.
Bei Li XIE ; Ming Wang LIU ; Bo Ce SONG ; Yu Long BIE ; Fu Hai ZHAO
Chinese Journal of Cardiology 2023;51(4):415-417
4.Advances in Modeling of Multiple Myeloma in Mice.
Xin-Yuan GU ; Wen-Jiao TANG ; Yan LI ; Li ZHANG ; Yu-Huan ZHENG
Acta Academiae Medicinae Sinicae 2023;45(3):512-518
Multiple myeloma(MM)is a systemic malignancy of plasma cells.Nowadays,the basic research on MM is flourishing with the continuous optimization and innovation of mouse models of MM.Heterologous mouse models of MM established with human-derived cells and immunodeficient mice have been applied in assessing drug efficacy,exploring drug resistance mechanisms,and observing tumor-bone marrow microenvironment interactions.In the last decades,the homologous mouse models of MM established with murine-derived cells or gene-editing technologies have been widely used in the research on the pathogenesis and drug development.Additionally,the stable modeling of targeted organ injury will be a key problem to be tackled in this field.This review summarizes the characteristics and application progress of mouse models of MM.
Humans
;
Animals
;
Mice
;
Multiple Myeloma/pathology*
;
Bone Marrow/pathology*
;
Disease Models, Animal
;
Drug Resistance
;
Tumor Microenvironment
5.Research progress on chemical constituents of Schisandra chinensis and its effect on nonalcoholic fatty liver disease.
Xin-Lu MU ; Bin LI ; Yu-Cen ZOU ; Jiu-Shi LIU ; Ben-Gang ZHANG ; Pei-Gen XIAO ; Hai-Tao LIU
China Journal of Chinese Materia Medica 2023;48(4):861-878
Schisandra chinensis, a traditional Chinese medicinal herb, is rich in chemical constituents, including lignans, triterpenes, polysaccharides, and volatile oils. Clinically, it is commonly used to treat cardiovascular, cerebrovascular, liver, gastrointestinal, and respiratory diseases. Modern pharmacological studies have shown that S. chinensis extract and monomers have multiple pharmacological activities in lowering liver fat, alleviating insulin resistance, and resisting oxidative stress, and have good application prospects in alleviating nonalcoholic fatty liver disease(NAFLD). Therefore, this study reviewed the research progress on chemical constituents of S. chinensis and its effect on NAFLD in recent years to provide references for the research on S. chinensis in the treatment of NAFLD.
Non-alcoholic Fatty Liver Disease
;
Schisandra
;
Insulin Resistance
;
Lignans
6.Incidence and related factors of antiviral drug resistance in HIV-infected pregnant and postpartum women in some areas of three western provinces of China from 2017 to 2019.
He SUN ; Ai Ling WANG ; Jun YAO ; Jia Rui ZHENG ; Qing Hua QIN ; Wu Li SHA ; Xiao Yan WANG ; Ya GAO ; Zhen LI ; Dong Xu HUANG ; Qian WANG
Chinese Journal of Preventive Medicine 2023;57(11):1788-1793
Objective: To analyze the incidence and related factors of drug resistance in HIV-infected pregnant and postpartum women in some areas of three western provinces of China from 2017 to 2019. Methods: From April 2017 to April 2019, face-to-face questionnaires and blood sample testing were conducted in all health care institutions providing maternal and perinatal care and midwifery-assisted services in 7 prevention of mother-to-child transmissi project areas in Xinjiang, Yunnan and Guangxi provinces/autonomous regions. Information was collected during the perinatal period and viral load, CD4+T lymphocytes and drug resistance genes were detected at the same time. The multivariate logistic regression model was used to analyze the relationship between different factors and drug resistance in HIV-infected pregnant and postpartum women. Results: A total of 655 HIV-infected pregnant and postpartum women were included in this study. The incidence of drug resistance was 3.4% (22/655), all of whom were cross-drug resistant. The rate of low, moderate and high drug resistance was 2.1% (14/655), 1.2% (8/655) and 0.8% (5/655), respectively. The drug resistance rate in the people who had previously used antiviral drugs was 1.9% (8/418), and the drug resistance rate in the people who had not used drugs was 5.9% (14/237). The NNRTI drug resistance accounted for 2.8% (18/655) and the NRTI drug resistance rate was 2.5% (16/655). The multivariate logistic regression model showed that the risk of HIV resistance was lower in pregnant women who had previously used antiviral drugs (OR=0.32, 95%CI: 0.11-0.76). Conclusion: Strengthening the management of antiviral drug use and focusing on pregnant and postpartum women who have not previously used antiviral drugs can help reduce the occurrence of drug-resistant mutations. Personalized antiviral therapy should be considered to achieve viral inhibition effects in clinical practice.
Female
;
Humans
;
Pregnancy
;
HIV Infections/drug therapy*
;
Incidence
;
China/epidemiology*
;
Infectious Disease Transmission, Vertical/prevention & control*
;
Postpartum Period
;
Drug Resistance, Viral/genetics*
;
Antiviral Agents/therapeutic use*
7.Incidence and related factors of antiviral drug resistance in HIV-infected pregnant and postpartum women in some areas of three western provinces of China from 2017 to 2019.
He SUN ; Ai Ling WANG ; Jun YAO ; Jia Rui ZHENG ; Qing Hua QIN ; Wu Li SHA ; Xiao Yan WANG ; Ya GAO ; Zhen LI ; Dong Xu HUANG ; Qian WANG
Chinese Journal of Preventive Medicine 2023;57(11):1788-1793
Objective: To analyze the incidence and related factors of drug resistance in HIV-infected pregnant and postpartum women in some areas of three western provinces of China from 2017 to 2019. Methods: From April 2017 to April 2019, face-to-face questionnaires and blood sample testing were conducted in all health care institutions providing maternal and perinatal care and midwifery-assisted services in 7 prevention of mother-to-child transmissi project areas in Xinjiang, Yunnan and Guangxi provinces/autonomous regions. Information was collected during the perinatal period and viral load, CD4+T lymphocytes and drug resistance genes were detected at the same time. The multivariate logistic regression model was used to analyze the relationship between different factors and drug resistance in HIV-infected pregnant and postpartum women. Results: A total of 655 HIV-infected pregnant and postpartum women were included in this study. The incidence of drug resistance was 3.4% (22/655), all of whom were cross-drug resistant. The rate of low, moderate and high drug resistance was 2.1% (14/655), 1.2% (8/655) and 0.8% (5/655), respectively. The drug resistance rate in the people who had previously used antiviral drugs was 1.9% (8/418), and the drug resistance rate in the people who had not used drugs was 5.9% (14/237). The NNRTI drug resistance accounted for 2.8% (18/655) and the NRTI drug resistance rate was 2.5% (16/655). The multivariate logistic regression model showed that the risk of HIV resistance was lower in pregnant women who had previously used antiviral drugs (OR=0.32, 95%CI: 0.11-0.76). Conclusion: Strengthening the management of antiviral drug use and focusing on pregnant and postpartum women who have not previously used antiviral drugs can help reduce the occurrence of drug-resistant mutations. Personalized antiviral therapy should be considered to achieve viral inhibition effects in clinical practice.
Female
;
Humans
;
Pregnancy
;
HIV Infections/drug therapy*
;
Incidence
;
China/epidemiology*
;
Infectious Disease Transmission, Vertical/prevention & control*
;
Postpartum Period
;
Drug Resistance, Viral/genetics*
;
Antiviral Agents/therapeutic use*
8.Protective Roles of Shilajit in Modulating Resistin, Adiponectin, and Cytokines in Rats with Non-alcoholic Fatty Liver Disease.
Baran GHEZELBASH ; Nader SHAHROKHI ; Mohammad KHAKSARI ; Gholamreza ASADIKARAM ; Maryam SHAHROKHI ; Sara SHIRAZPOUR
Chinese journal of integrative medicine 2022;28(6):531-537
OBJECTIVE:
To evaluate the effect of Shilajit, a medicine of Ayurveda, on the serum changes in cytokines and adipokines caused by non-alcoholic fatty liver disease (NAFLD).
METHODS:
After establishing fatty liver models by feeding a high-fat diet (HFD) for 12 weeks, 35 Wistar male rats were randomly divided into 5 groups, including control (standard diet), Veh (HFD + vehicle), high-dose Shilajit [H-Sh, HFD + 250 mg/(kg·d) Shilajit], low-dose Shilajit [L-Sh, HFD + 150 mg/(kg·d) Shilajit], and pioglitazone [HFD + 10 mg/(kg·d) pioglitazone] groups, 7 rats in each group. After 2-week of gavage administration, serum levels of glucose, insulin, interleukin 1beta (IL-1β), IL-6, IL-10, tumor necrosis factor-alpha (TNF-α), adiponectin, and resistin were measured, and insulin resistance index (HOMA-IR) was calculated.
RESULTS:
After NAFLD induction, the serum level of IL-10 significantly increased and serum IL-1β, TNF-α levels significantly decreased by injection of both doses of Shilajit and pioglitazone (P<0.05). Increases in serum glucose level and homeostasis model of HOMA-IR were reduced by L-Sh and H-Sh treatment in NAFLD rats (P<0.05). Both doses of Shilajit increased adiponectin and decreased serum resistin levels (P<0.05).
CONCLUSION
The probable protective role of Shilajit in NAFLD model rats may be via modulating the serum levels of IL-1β, TNF-α, IL-10, adipokine and resistin, and reducing of HOMA-IR.
Adiponectin
;
Animals
;
Cytokines
;
Diet, High-Fat
;
Glucose
;
Insulin Resistance
;
Interleukin-10
;
Liver
;
Male
;
Minerals
;
Non-alcoholic Fatty Liver Disease/pathology*
;
Pioglitazone/therapeutic use*
;
Rats
;
Rats, Wistar
;
Resins, Plant
;
Resistin/therapeutic use*
;
Tumor Necrosis Factor-alpha
9.Index of microcirculatory resistance: state-of-the-art and potential applications in computational simulation of coronary artery disease.
Yingyi GENG ; Xintong WU ; Haipeng LIU ; Dingchang ZHENG ; Ling XIA
Journal of Zhejiang University. Science. B 2022;23(2):123-140
The dysfunction of coronary microcirculation is an important cause of coronary artery disease (CAD). The index of microcirculatory resistance (IMR) is a quantitative evaluation of coronary microcirculatory function, which provides a significant reference for the prediction, diagnosis, treatment, and prognosis of CAD. IMR also plays a key role in investigating the interaction between epicardial and microcirculatory dysfunctions, and is closely associated with coronary hemodynamic parameters such as flow rate, distal coronary pressure, and aortic pressure, which have been widely applied in computational studies of CAD. However, there is currently a lack of consensus across studies on the normal and pathological ranges of IMR. The relationships between IMR and coronary hemodynamic parameters have not been accurately quantified, which limits the application of IMR in computational CAD studies. In this paper, we discuss the research gaps between IMR and its potential applications in the computational simulation of CAD. Computational simulation based on the combination of IMR and other hemodynamic parameters is a promising technology to improve the diagnosis and guide clinical trials of CAD.
Coronary Angiography
;
Coronary Artery Disease
;
Coronary Circulation
;
Humans
;
Microcirculation
;
Predictive Value of Tests
;
Vascular Resistance
10.Advances of miRNA-mediated regulatory roles in plant-microbe interaction.
Xiaoman LÜ ; Wenyi ZHANG ; Haihua ZHANG ; Zongsuo LIANG ; Haimin CHEN
Chinese Journal of Biotechnology 2022;38(5):1695-1705
There are many bidirectional communication and crosstalk between microbes and host plants. The plant-pathogen interaction directly affects the survival of host plants, while the interaction between plants and their probiotics benefits both. Plant miRNA responds quickly to pathogenic or beneficial microbes when they enter the plant tissues, while microbes also produce miRNA-like RNA (milRNA) to affect plant health. These means miRNA or milRNA is an important fast-responding molecular mediator in plant-microbe interactions, and these internal mechanisms have been better understood in recent years. This review summarized the regulatory roles of miRNA in plant-pathogens and plant-probiotics interaction. The regulatory role of miRNA in disease resistance of host plants during plant-pathogens interaction, and the regulatory role of miRNA in promoting host growth and development during plant-probiotics interaction, as well as the cross-kingdom regulatory role of milRNA in host plants, were discussed in-depth.
Disease Resistance
;
MicroRNAs/genetics*
;
Microbial Interactions
;
Plants/genetics*

Result Analysis
Print
Save
E-mail